Navigation Links
Dynatronics Announces Changes to Board and Launches Operational Improvement Process
Date:12/17/2008

SALT LAKE CITY, Dec. 17 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced changes to its board of directors and the execution of an agreement with a former director for consulting services designed to aid in strategic planning and improved corporate profitability. On December 15, 2008, the company entered into an agreement with Vici Capital Partners for consulting services through its principal, Mark Crockett. As a condition to the execution of the agreement, Mr. Crockett resigned from Dynatronics' board of directors, where he had served as an independent director.

"In his short time on the board, Mark Crockett provided tremendous insight and service," said Kelvyn Cullimore Jr., chief executive officer of Dynatronics. "While we regret losing his services as an independent director we are thrilled he is willing to make that sacrifice in order to roll up his sleeves on the inside of the company."

Mr. Crockett has previously led the operational turnaround efforts of a number of companies and will now be helping Dynatronics in an intensive effort to improve all aspects of its business. "After acquiring and integrating several of our key dealers this past year, we are now poised to complete the transformation of our company to more fully take advantage of our strategic strengths as a manufacturer and distributor of medical products for the physical medicine market," added Cullimore.

NASDAQ Marketplace Rules require that a majority of a company's board be comprised of independent directors. To maintain a majority of independent directors following Mr. Crockett's resignation, Dynatronics accepted the resignation of Kelvyn Cullimore, Sr., the company's founder and vice-chairman of the board. Mr. Cullimore's resignation from the board will not affect his duties managing Dynatronics' Synergie products division and Tennessee operations. The company's board of directors now has five members, three of whom are independent under applicable NASDAQ rules and SEC regulations.

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at http://www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2008, and its subsequent quarterly reports on Form 10-Q.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynatronics Announces Strong Fourth Quarter Profit
2. Dynatronics Adds Three Additional Direct Sales Reps
3. Dynatronics to Release First Quarter Results Monday, November 19, 2007; Conference Call Set for 1:30 p.m. ET
4. Dynatronics Acquisitions Increase Sales 91 Percent in First Quarter
5. Dynatronics Announces $250,000 Increase in Stock Buyback Program
6. Dynatronics to Release Second Quarter Results Thursday, February 14, 2008; Conference Call Set for 4:30 p.m. ET
7. Dynatronics Acquisitions Increase Sales 100 Percent in Second Quarter
8. Dynatronics Introduces New Synergie Elite Aesthetic Line
9. Dynatronics Introduces New DynaPro Spinal Health System and X5 Turbo
10. Dynatronics Reduces Annual Expenses by $1.9 Million
11. Dynatronics to Release Third Quarter Results Wednesday, May 14, 2008; Conference Call Set for 2:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
(Date:2/23/2017)... RYE, New York (PRWEB) , ... February 23, 2017 , ... ... to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, ... the 30 clinical sites already enrolling children across the United States. , “There ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane ... overwork even the sharpest brain. , Power On, a mental performance enhancer from ... clocking the brain. Each capsule contains Cognizin® Citicoline, a branded form of the ...
(Date:2/22/2017)... ... ... The National Academy of Certified Care Managers (NACCM) has ... period. NACCM, a nonprofit organization, has provided the premier certification for Care Managers ... to ensure that newly certified professionals are prepared to work effectively on behalf ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology: